Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives $3.67 Consensus Target Price from Analysts
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) has earned an average rating of “Hold” from the five ratings firms that are currently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1-year target price […]
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) has earned an average rating of “Hold” from the five ratings firms that are currently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1-year target price […]
